L-type calcium channels and calcium/calmodulin-dependent kinase II differentially mediate behaviors associated with nicotine withdrawal in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 1, 2009, Pages 152-161

  Jackson, Kia J ^a   Damaj, M I ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WITHDRAWAL SYNDROME;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; BEHAVIOR, ADDICTIVE; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; FEMALE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NICOTINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 67649884497     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.151530     Document Type: Article

References (25)

1. Biala G and Weglinska B (2005) Blockade of the expression of mecamylamineprecipitated nicotine withdrawal by calcium channel antagonists. Pharmacol Res 51:483-488.
2. 2+/ calmodulin-dependent kinase II alpha-subunit mutation. Proc Natl Acad Sci U S A 92:6852-6855.
3. Dajas-Bailador FA, Mogg AJ, and Wonnacott S (2002) Intracellular calcium signals evolved by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated calcium channels and calcium stores. J Neurochem 81:606-614.
4. Damaj MI (2000) The involvement of spinal calcium/calmodulin-protein kinase II in nicotine-induced antinociception in mice. Eur J Pharmacol 404:103-110.
5. Damaj MI (2005) Calcium-acting drugs modulate expression and development of nicotine-induced antinociception in mice. J Pharmacol Exp Ther 315:959-964.
6. Deisseroth K, Heist EK, and Tsien RW (1998) Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392: 198-202.
7. Frankland PW, O'Brien C, Ohno M, Kirkwood A, and Silva AJ (2001) α-CaMKIIdependent plasticity in the cortex is required for permanent memory. Nature 411:309-313.
8. Gao L, Blair LA, and Marshall J (2006) CaMKII-dependent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels. Biochem Biophys Res Commun 345:1606-1610.
9. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, and Reeves KR(2006) Veranicline, and α4β2 nicotinic acetylcholine receptor partial agonist vs. sustained- release bupropion and placebo for smoking cessation. JAMA 296:47-55.
10. 2+/CaM-dependent kinases: from activation to function. Annu Rev Pharmacol Toxicol 41:471-505. Review.
11. Jackson KJ, Martin BR, Changeux JP, and Damaj MI (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325:302-312.
12. Katsura M, Mohri Y, Shuto K, Hai-Du Y, Amano T, Tsujimura A, Sasa M, and Ohkuma S (2002) Up-regulation of L-type voltage-dependent calcium channels after long term exposure to nicotine in cerebral cortical neurons. J Biol Chem 277:7979-7988.
13. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, and Britton KT (1993) The role of corticotropin-releasing factor in behavioral responses to stress. Ciba Found Symp 172:277-289; discussion 290-295.
14. Lisman J, Schulman H, and Cline H (2002) The molecular basis of CaMKII function in synaptic and behavioral memory. Nature 3:175-190.
15. Liu Q and Berg DK (1999) Actin filaments and the opposing actions on CaM kinase II and calcineurin in regulating α7-containing nicotinic receptors on chick ciliary ganglion neurons. J Neurosci 19:10280-10288.
16. MacNicol M and Schulman H (1992) Multiple Calcium signaling pathways converge on CaM kinase in PC12 cells. FEBS Lett 304:237-240.
17. Markou A, Kosten TR, and Koob GF (1998) Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 18:135-174.
18. Matta SG, McCoy JG, Foster CA, and Sharp BM (1995) Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion on the hypothalamic paraventricular nucleus: an in vivo microdialysis study. Neuroendocrinology 61:383-392.
19. Rathouz MM and Berg DK (1994) Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J Neurosci 14:6935-6945.
20. Schulman H and Hanson PI (1993) Multifunctional Calcium /calmodulin-dependent protein kinase. Neurochem Res 18:65-77.
21. Silva AJ, Paylor R, Wehner JM, and Tonegawa S (1992a) Impaired spatial learning in α-calcium-calmodulin kinase II mutant mice. Science 257:206-211.
22. Silva AJ, Stevens CF, Tonegawa S, and Wang Y (1992b) Deficient hippocampal long-term potentiation in α-calcium calmodulin kinase II mutant mice. Science 257:201-206.
23. Steiner RC, Heath CJ, and Picciotto MR (2007) Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII. J Neurochem 103:666-678.
24. West RJ, Hajek P, and Belcher M (1989) Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 19:981-985.
25. Wheeler DG, Barrett CF, and Tsien RW (2006) L-type calcium channel ligands block nicotine-induced signaling to CREB by inhibiting nicotinic receptors. Neuropharmacology 51:27-36.